Skip to main content

and
  1. Article

    CTDP-32476: A Promising Agonist Therapy for Treatment of Cocaine Addiction

    Agonist-replacement therapies have been successfully used for treatment of opiate and nicotine addiction, but not for cocaine addiction. One of the major obstacles is the cocaine-like addictive potential of th...

    Zheng-**ong **, Rui Song, **a Li, Guan-Yi Lu, **ao-Qing Peng in Neuropsychopharmacology (2017)

  2. Article

    Is Slow-Onset Long-Acting Monoamine Transport Blockade to Cocaine as Methadone is to Heroin? Implication for Anti-Addiction Medications

    The success of methadone in treating opiate addiction has suggested that long-acting agonist therapies may be similarly useful for treating cocaine addiction. Here, we examined this hypothesis, using the slow-...

    **ao-Qing Peng, Zheng-**ong **, **a Li, Krista Spiller, Jie Li in Neuropsychopharmacology (2010)

  3. No Access

    Article

    Conformational preferences of the potent dopamine reuptake blocker BTCP and its analogs and their incorporation into a pharmacophore model

    Molecular mechanics calculations using MM3-92 and ab initio quantum mechanical calculations using SPARTAN 5.0 were performed on the structurally similar PCP and BTCP, in which only the latter has a cocaine-lik...

    Mark Froimowitz, Kuo-Ming Wu, Jason Rodrigo in Journal of Computer-Aided Molecular Design (2000)

  4. No Access

    Article

    Crystal Structures of Analogs of threo-Methylphenidate

    The crystal structures of the chloride salts of five analogs of threo-methylphenidate have been obtained. Four of these have different substituents on the phenyl ring while the fifth is the ethyl ester of methylp...

    Mark Froimowitz, Kuo-Ming Wu, Clifford George, Don VanDerveer in Structural Chemistry (1998)

  5. No Access

    Article

    Crystal structure of the meta hydroxyl phenyl analog of α(+)-prodine

    The meta hydroxyphenyl analog of α-prodine (1,3-dimethyl-(4-meta-hydroxy phenyl)-4-propionyloxypiperidine) free base crystallizes in the orthorhombic space group P212121. The relative configuration of the compoun...

    Vivian Cody, Naiyin Li, Atmaram D. Khanolkar in Journal of Chemical Crystallography (1996)

  6. No Access

    Article

    Conformational Analysis of Methylphenidate and Its Structural Relationship to Other Dopamine Reuptake Blockers Such as CFT

    Purpose. This work was performed 1) to determine the conformational preferences of the threo and erythro isomers of the dopamine reuptake blocker methylphenidate, 2) to determine the crystal conformation of the

    Mark Froimowitz, Kennerly S. Patrick, Vivian Cody in Pharmaceutical Research (1995)

  7. No Access

    Article

    Structural Factors that Distinguish Dopamine D1 and D2 Agonists

    To determine the structural features responsible for their selectivity as dopamine D1 agonists, a conformational analysis has been performed on an analog of nomifensine, dihydrexidine, a benzergoline, and an ...

    Mark Froimowitz, Emile M. Bellott, Jr. in Molecular modeling annual (1995)

  8. No Access

    Article

    Conformational Analysis of the Opioid Phenylmorphan and Its 9α-Methyl Analogue in Solution Using High-Resolution Nuclear Magnetic Resonance Spectroscopy

    The solution conformations of the opioid phenylmorphan (5-m-hydroxyphenyl-2-methylmorphan) and its 9α-methyl analogue were studied using one- and two-dimensional high resolution NMR techniques. The NMR spectra we...

    Christine M. DiMeglio, Mark Froimowitz, Alexandros Makriyannis in Pharmaceutical Research (1993)

  9. No Access

    Article

    Butaclamol: Absolute configuration, crystal and molecular conformation

    (−)-Butaclamol HCl, C25H31ONCl, crystallizes in the monoclinic space group P21 with cell dimensionsa=12.842(2),b=7.741(1),c=11.667(2)Å andβ=106.54(2)°,z=2. Refinement of nonhydrogen atoms with anisotropic thermal...

    Vivian Cody, Mark Froimowitz in Journal of Crystallographic and Spectroscopic Research (1990)